A PATIENT WITH DILATED CARDIOMYOPATHY: CHRONIC HEART FAILURE AND HIGH RISK OF SUDDEN CARDIAC DEATH
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
Abstract
The results of assessment and treatment of a 49 year old patient with dilated cardiomyopathy combined with chronic heart failure using the best medical therapy and cardiac resynchronization therapy are given.
About the Authors
M. V. Berman
Северо-западный центр диагностики и лечения аритмий Санкт-Петербургского государственного
Russian Federation
Russian Federation
M. A. Baturova
Северо-западный центр диагностики и лечения аритмий Санкт-Петербургского государственного
Russian Federation
Russian Federation
T. V. Kryatova
Северо-западный центр диагностики и лечения аритмий Санкт-Петербургского государственного
Russian Federation
Russian Federation
I. V. Aparina
Северо-западный центр диагностики и лечения аритмий Санкт-Петербургского государственного
Russian Federation
Russian Federation
References
1. Gordeeva M.V., Veleslavova O.E., Baturova M.A. i dr. Vnezapnaya nenasil'stvennaya smert' molodykh lyudei (retrospektivnyi analiz) // Vestnik aritmologii, 2011, Tom 65, s.25-32.
2. Gordeeva M.V., Mitrofanova L.B., Pakhomov A.V. i dr. Vnezapnaya serdechnaya smert' molodykh lyudei // Vestnik aritmologii, 2012, Tom 68, s.34-44.
3. Gordeeva M.V., Mitrofanova L.B., Pakhomov A.V. i dr. Aritmogennaya kardiomiopatiya/displaziya pravogo zheludochka kak prichina vnezapnoi serdechnoi smerti molodykh lyudei // Vestnik aritmologii, 2012, Tom 69, s.38-48.
4. Iyer V.R., Chin A.J. Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) // Am. J. Med. Genet. C Semin. Med. Genet. 2013 Aug; 163C(3): 185-97.
5. Hensley N., Dietrich J., Nyhan D. et al. Hypertrophic cardiomyopathy: a review // Anesth Analg. 2015 Mar; 120(3): 554-69.
6. Hussein A., Karimianpour A., Collier P., Krasuski RA., Isolated Noncompaction of the Left Ventricle in Adults // J. Am. Coll. Cardiol. 2015 Aug 4; 66(5): 578-85.
7. Hershberger R.E., Hedges D.J., Morales A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture // Nat Rev Cardiol. 2013 Sep; 10(9): 531-47.
8. Spinarova L., Spinar J. Pharmacotherapy of dilated cardiomyopathy. //Curr Pharm Des. 2015; 21(4): 449-58.
9. Saxon L.A., Bristow M.R., Boehmer J., et al. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial // Circulation. 2006 Dec 19; 114(25): 2766-72.
10. Anand I.S., Carson P., Galle E. et al. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial // Circulation. 2009 Feb 24; 119(7): 969-77.
11. Cleland J.G., Daubert J.C., Erdmann E. etal. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase] // Eur Heart J. 2006 Aug; 27(16): 1928-32.
12. Richardson M., Freemantle N., Calvert M.J. et al. Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial // Eur Heart J. 2007 Aug; 28(15): 1827-34.
Review
For citations:
Berman M.V., Baturova M.A., Kryatova T.V., Aparina I.V. A PATIENT WITH DILATED CARDIOMYOPATHY: CHRONIC HEART FAILURE AND HIGH RISK OF SUDDEN CARDIAC DEATH. Journal of Arrhythmology. 2015;(81):42-46. (In Russ.)
Views:
120
ISSN 1561-8641 (Print)
ISSN 2658-7327 (Online)
ISSN 2658-7327 (Online)
Email this article 